pvl-, muPA-, and qacA/B-specific PCRs Isolates were tested for th

pvl-, muPA-, and qacA/B-specific PCRs Isolates were tested for the presence of the Panton-Valentine leukocidin gene (pvl), mupirocin-resistance protein-encoding gene (muPA), and chlorhexidine-based

antiseptic resistance loci (qacA/B) by PCR using the following primers: pvl-F 5′-ATCATTAGGTAAAATGTCTGGACATGATCCA-3′, pvl-R 5′-GCATCAACTGTATTGGATAGCAAAAGC-3′ (PCR product size: 433 bp); muPA–F 5′-CATTGGAAGATGAAATGCATACC-3′, muPA–R 5′-CGCAGTCATTATCTTCACTGAG-3′ (PCR product size: 443 bp); qacA/B-F 5′-CTATGGCAATAGGAGATATGGTGT-3′, qacA/B-R 5′-CCACTACAGATTCTTCAGCTACATG-3′ (PCR product size: 416 bp). The amplification was carried out on a GeneAmp 9700 thermal cycler (Applied Biosystems, NY, USA) under the following conditions: an initial 5 min denaturation at 94°C, followed by 35 cycles CUDC-907 manufacturer of 30 s at 94°C, 30 s at 55°C, and 30 s at 72°C, with a final extension at 72°C for 7 min. In each PCR, a positive control and a negative control (distilled water) were included. The PCR fragments were visualized by agarose gel electrophoresis and ethidium bromide staining.

Statistical analysis Statistical analyses were performed using Stata software (version 10.1/SE, Stata Corp, College Station, TX, USA). We used the χ 2 and Fisher’s exact tests, as appropriate for analysis of categorical data. Statistical significance was set at P ≤0.05. Acknowledgements This study was supported by the SGC-CBP30 manufacturer National Natural Science Foundation of China (grants 81171623 and 81261120387), Outstanding Young Talent Plan of Shanghai (XYQ2011039), and Shanghai Shuguang Talent Project (12SG03). References 1. Dryden MS: Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009,34(Suppl 1):S2-S7.PubMedCrossRef 2. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339:520–532.PubMedCrossRef 3. Chambers HF, Deleo FR: Waves of resistance: Pregnenolone staphylococcus aureus in the antibiotic era. Nat Rev MDV3100 chemical structure Microbiol 2009, 7:629–641.PubMedCrossRef 4. Wang H, Liu Y, Sun H,

Xu Y, Xie X, Chen M: In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China. Diagn Microbiol Infect Dis 2008, 62:226–229.PubMedCrossRef 5. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG: The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002, 99:7687–7692.PubMedCrossRef 6. Chen H, Liu Y, Jiang X, Chen M, Wang H: Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother 2010, 54:1842–1847.PubMedCrossRef 7. Xu BL, Zhang G, Ye HF, Feil EJ, Chen GR, Zhou XM, Zhan XM, Chen SM, Pan WB: Predominance of the Hungarian clone (ST 239-III) among hospital-acquired meticillin-resistant Staphylococcus aureus isolates recovered throughout mainland China. J Hosp Infect 2009, 71:245–255.PubMedCrossRef 8.

Comments are closed.